MLSS vs. ERNA
MLSS (Milestone Scientific Inc.) and ERNA (Eterna Therapeutics Inc) are both stocks. Both are in the Healthcare sector — MLSS in Medical Instruments & Supplies, ERNA in Biotechnology. Over the past 10 years, MLSS returned -18.21%/yr vs -62.07%/yr for ERNA. At a 0.06 correlation, their price movements are largely independent.
Performance
MLSS vs. ERNA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MLSS achieves a 39.89% return, which is significantly higher than ERNA's -79.80% return. Over the past 10 years, MLSS has outperformed ERNA with an annualized return of -18.21%, while ERNA has yielded a comparatively lower -62.07% annualized return.
MLSS
- 1D
- 7.58%
- 1M
- 9.11%
- 6M
- 29.94%
- YTD
- 39.89%
- 1Y
- -42.69%
- 3Y*
- -29.50%
- 5Y*
- -28.33%
- 10Y*
- -18.21%
ERNA
- 1D
- 2.19%
- 1M
- -1.46%
- 6M
- -81.50%
- YTD
- -79.80%
- 1Y
- -87.57%
- 3Y*
- -81.25%
- 5Y*
- -85.57%
- 10Y*
- -62.07%
MLSS vs. ERNA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
MLSS Milestone Scientific Inc. | 39.89% | -71.56% | 39.15% | 43.73% | -76.70% | -2.83% | 52.52% | 319.18% | -71.92% | -15.64% |
ERNA Eterna Therapeutics Inc | -79.80% | -72.79% | -83.62% | -44.25% | -96.14% | -6.92% | 1.82% | 12.82% | -53.68% | -50.47% |
Correlation
The correlation between MLSS and ERNA is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.12 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.08 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.17 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.11 |
Correlation (All Time) Calculated using the full available price history since Nov 3, 1995 | 0.06 |
The correlation between MLSS and ERNA shifts across timeframes, from 0.06 (all time) to 0.17 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
MLSS:
$33.78M
ERNA:
$1.90M
MLSS:
-$0.08
ERNA:
-$23.80
MLSS:
$8.93M
ERNA:
$0.00
MLSS:
$6.40M
ERNA:
-$69.00K
MLSS:
-$6.49M
ERNA:
-$11.25M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MLSS vs. ERNA — Risk / Return Rank
MLSS
ERNA
MLSS vs. ERNA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Milestone Scientific Inc. (MLSS) and Eterna Therapeutics Inc (ERNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MLSS | ERNA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.09 | ||
| Sortino ratioReturn per unit of downside risk | +0.81 | ||
| Omega ratioGain probability vs. loss probability | 0.96 | 0.87 | +0.10 |
| Calmar ratioReturn relative to maximum drawdown | -0.68 | -0.94 | +0.26 |
| Martin ratioReturn relative to average drawdown | -0.96 | -1.38 | +0.42 |
Loading charts...
Drawdowns
MLSS vs. ERNA - Drawdown Comparison
The maximum MLSS drawdown since its inception was -99.77%, roughly equal to the maximum ERNA drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for MLSS and ERNA.
Loading charts...
Drawdown Indicators
| MLSS | ERNA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.77% | -100.00% | +0.23% |
Max Drawdown (1Y)Largest decline over 1 year | -63.03% | -93.32% | +30.29% |
Max Drawdown (3Y)Largest decline over 3 years | -81.47% | -99.67% | +18.20% |
Max Drawdown (5Y)Largest decline over 5 years | -90.91% | -100.00% | +9.09% |
Max Drawdown (10Y)Largest decline over 10 years | -94.72% | -100.00% | +5.28% |
Current DrawdownCurrent decline from peak | -99.55% | -100.00% | +0.45% |
Average DrawdownAverage peak-to-trough decline | -91.21% | -86.18% | -5.03% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 45.28% | 63.64% | -18.36% |
Volatility
MLSS vs. ERNA - Volatility Comparison
Milestone Scientific Inc. (MLSS) and Eterna Therapeutics Inc (ERNA) have volatilities of 25.47% and 26.61%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MLSS | ERNA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 25.47% | 26.61% | -1.14% |
Volatility (6M)Calculated over the trailing 6-month period | 61.75% | 130.04% | -68.29% |
Volatility (1Y)Calculated over the trailing 1-year period | 88.32% | 151.77% | -63.45% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 84.94% | 114.08% | -29.14% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 87.52% | 149.04% | -61.52% |
Dividends
MLSS vs. ERNA - Dividend Comparison
Neither MLSS nor ERNA has paid dividends to shareholders.
Financials
MLSS vs. ERNA - Financials Comparison
This section allows you to compare key financial metrics between Milestone Scientific Inc. and Eterna Therapeutics Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
MLSS and ERNA have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ERNA has higher volatility (26.61%) compared to MLSS (25.47%). In terms of maximum drawdown, MLSS dropped -99.77% vs ERNA's -100.00%.
MLSS currently has the higher Sharpe Ratio (-0.49 vs -0.58), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MLSS and ERNA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer